儿童球孢子菌病管理存在较大差异
本研究回顾性分析2015至2021年Kaiser Permanente Southern California系统中209例17岁及以下新诊断球孢子菌病(CM)患儿,发现发病率为3.3/10万儿童,常见症状为发热、咳嗽和皮疹(均>59%),播散性CM占4.8%;未播散感染者中观察组仅1.2%需治疗,治疗组中位疗程150天,停药后复发率2.1%,临床管理差异大。
要点
- 儿童CM常见症状为发热、咳嗽和皮疹,播散性感染占4.8%。
- 无播散感染者观察失败率低(1.2%),治疗组停药后复发率2.1%。
- 无症状患者初始诊断后的血清学检测通常不改变临床管理。
核心结论
- 儿童球孢子菌病的临床管理存在广泛的医生间差异。
- 治疗后复发或未抗真菌观察失败均罕见。
- 无症状患者初始诊断外的血清学检测通常不改变临床管理,而症状随访对管理重要。
主要发现
- 共识别209例CM患者,发病率为3.3例/10万儿童,但在KPSC覆盖区域内有所变化。
- 常见症状为发热、咳嗽和皮疹,每种症状发生率均>59%。
- 播散性CM见于10例患者(4.8%)。
- 199例无播散性感染患者中,57例未接受抗真菌治疗观察,其中1例(1.2%)最终需要治疗。
- 142例接受抗真菌治疗的患者中位治疗时间为150天(范围从<3个月至>2年),停药后3例(2.1%)复发。
关键数值与推荐
- 播散性CM占4.8%(10/209)。
- 未治疗观察组需治疗比例为1.2%(1/57)。
- 治疗组中位疗程150天(范围<3个月至>2年)。
- 停药后复发率为2.1%(3/142)。
临床怎么用
- 对于无播散性感染的儿童CM,可考虑观察而不立即抗真菌治疗,因观察失败率低。
- 抗真菌治疗疗程可能较长,中位150天,需个体化。
- 随访应重点关注症状,无症状患者初始诊断后的血清学检测通常不改变管理。
局限性
- 本研究为回顾性病历审查,可能存在记录偏倚。
- 研究仅限于Kaiser Permanente Southern California系统,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Coccidioidomycosis (CM) is not as well described in children as it is in adults. The Kaiser Permanente Southern California (KPSC) system provides care within an endemic region for CM, affording the opportunity to describe the diagnosis, management, and outcomes of CM in a large pediatric cohort. METHODS: This study is a retrospective manual medical record review of patients aged 17 years or younger with a new diagnosis of CM between January 1, 2015, and December 31, 2021. We extracted demographic characteristics, symptoms, diagnostic testing, and details of patient management. RESULTS: CM was identified in 209 patients. The incidence was 3.3 cases per 100 000 children but varied within the area covered by KPSC. Common symptoms were fever, cough, and rash (>59% for each). Disseminated CM was present in 10 patients (4.8%). Of the 199 patients without disseminated infections, 57 were observed without antifungal treatment; 1 (1.2%) eventually required treatment. For the remaining 142 patients treated with antifungals, the median duration of treatment was 150 days (ranging from <3 months to >2 years). After stopping treatment, 3 (2.1%) had recurrence. Recurrence was identified primarily based on symptoms rather than serologic testing, and all responded well to treatment. CONCLUSIONS: Wide clinician variability in the management of pediatric coccidioidomycosis was observed. Recurrence after treatment or failure of observation without antifungals was rare. Results from serologic testing outside of the initial diagnosis in asymptomatic patients typically did not change clinical management, while symptomatic follow-up was important for management.
引用
- Michienzie C, Galgiani J, Fitzwater SP, et al. Variation in Management of Children With Coccidioidomycosis. Pediatrics. 2026. PMID: 41819487. doi:10.1542/peds.2025-073730
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。